Pharmaceutical

HEOR explained: Improving healthcare decisions with real-world evidence

How longitudinal, closed claims data is advancing regulatory, epidemiology, and health economics and outcomes research (HEOR).

Jan 18, 2025 - 06:00
HEOR explained: Improving healthcare decisions with real-world evidence
How longitudinal, closed claims data is advancing regulatory, epidemiology, and health economics and outcomes research (HEOR).
Read the original article

Tags:

Previous Article

Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?

Next Article

Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pharmanovia signs licence deal for Aeterna Zentaris’ Ghryvelin

Pharmanovia signs licence deal for Aeterna Zentaris’ Gh...

Mar 19, 2023

EC upgrades approval for J&J’s Rybrevant/chemotherapy combination in NSCLC

EC upgrades approval for J&J’s Rybrevant/chemotherapy c...

Aug 29, 2024

SGNB-7H4V by Pfizer for Peritoneal Cancer: Likelihood of Approval

SGNB-7H4V by Pfizer for Peritoneal Cancer: Likelihood o...

Jun 20, 2024